The Recall Desk

FDA (Drugs) recall action 91451

Nephron Sc Inc recalled 2 products on 2023-02-01

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2023-02-01
Critical
0
Units
1,312,920

Why these products were recalled

Short Fill

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

States named across these recalls

1–2 of 2

  • HighFDA (Drugs)··2023-02-01

    Asthmanefrin Bronchodilator Medication Vials Recalled Nationwide for Short Fill

    Nephron Sc Inc is recalling 387,000 vials of Asthmanefrin Racepinephrine Inhalation Solution due to short fill issues. The vials may contain insufficient solution, potentially affecting medication dosing.

    Product
    Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4
    Category
    Distribution
    1 state
  • ModerateFDA (Drugs)··2023-02-01

    Drug Recall: S2 Racepinephrine Inhalation Solution Short Fill

    Nephron Sc Inc recalls approximately 925,920 vials of S2 Racepinephrine Inhalation Solution due to short fill. Affected lots may contain less medication than labeled.

    Product
    S2 (RACEPINEPHRINE HYDROCHLORIDE)
    Category
    Distribution
    1 state